SI1761520T1 - Inhibitorji kinaze - Google Patents
Inhibitorji kinazeInfo
- Publication number
- SI1761520T1 SI1761520T1 SI200530351T SI200530351T SI1761520T1 SI 1761520 T1 SI1761520 T1 SI 1761520T1 SI 200530351 T SI200530351 T SI 200530351T SI 200530351 T SI200530351 T SI 200530351T SI 1761520 T1 SI1761520 T1 SI 1761520T1
- Authority
- SI
- Slovenia
- Prior art keywords
- kinase inhibitors
- formula
- present
- inhibitors
- provides kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04380131A EP1609789A1 (en) | 2004-06-23 | 2004-06-23 | Ureido-pyrazole derivatives and their use as kinase inhibitors |
US59253904P | 2004-07-30 | 2004-07-30 | |
EP04380174 | 2004-08-23 | ||
US62249204P | 2004-10-27 | 2004-10-27 | |
EP05766569A EP1761520B1 (en) | 2004-06-23 | 2005-06-15 | Kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1761520T1 true SI1761520T1 (sl) | 2008-10-31 |
Family
ID=43875180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200530351T SI1761520T1 (sl) | 2004-06-23 | 2005-06-15 | Inhibitorji kinaze |
Country Status (9)
Country | Link |
---|---|
US (1) | US7767674B2 (sl) |
EP (1) | EP1761520B1 (sl) |
AT (1) | ATE400567T1 (sl) |
DK (1) | DK1761520T3 (sl) |
ES (1) | ES2308523T3 (sl) |
PL (1) | PL1761520T3 (sl) |
PT (1) | PT1761520E (sl) |
SI (1) | SI1761520T1 (sl) |
WO (1) | WO2006009741A1 (sl) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2520763A1 (en) | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
JP2007532484A (ja) | 2004-03-16 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法 |
EP1814875A4 (en) | 2004-10-20 | 2010-02-17 | Univ California | IMPROVED INHIBITORS OF SOLUBLE HYDROLASE EPOXYDE |
TWI325423B (en) * | 2005-10-28 | 2010-06-01 | Lilly Co Eli | Kinase inhibitors |
DOP2006000233A (es) * | 2005-10-28 | 2007-06-15 | Lilly Co Eli | Inhibidores de cinasa |
TW200808723A (en) * | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
WO2009002916A2 (en) * | 2007-06-26 | 2008-12-31 | Smithkline Beecham Corporation | Processes for preparing benzimidazole thiophenes |
US8314091B2 (en) | 2007-08-20 | 2012-11-20 | Msd Oss B.V. | N-benzyl,N'-arylcarbonylpiperazine derivatives |
MY161992A (en) | 2008-03-26 | 2017-05-31 | Daiichi Sankyo Co Ltd | Novel tetrahydroisoquinoline derivative |
TW201022230A (en) * | 2008-08-28 | 2010-06-16 | Organon Nv | 1-(4-ureidobenzoyl)piperazine derivatives |
GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
CN102256964A (zh) | 2008-10-02 | 2011-11-23 | 瑞斯比维特有限公司 | p38MAP激酶抑制剂 |
MX2011006220A (es) | 2008-12-11 | 2011-06-28 | Respivert Ltd | Inhibidores de la proteina cinasa activada por el mitogeno p38. |
EA201190119A1 (ru) | 2009-02-17 | 2012-05-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ МАР-КИНАЗЫ p38 |
GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
JP2013506691A (ja) * | 2009-10-02 | 2013-02-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | ホスファチジルイノシトール3−キナーゼのピラゾール阻害薬 |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
EP2528604B1 (en) | 2010-01-29 | 2017-11-22 | The Regents of the University of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
CN103974953B (zh) | 2011-12-09 | 2016-06-29 | 奇斯药制品公司 | 激酶抑制剂 |
KR101994381B1 (ko) | 2011-12-09 | 2019-06-28 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
US9150570B2 (en) * | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
BR112015029970A2 (pt) | 2013-06-06 | 2017-07-25 | Chiesi Farm Spa | inibidores de cinase |
EP3394058B1 (en) | 2015-12-23 | 2020-10-14 | Chiesi Farmaceutici S.p.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
TW201730189A (zh) | 2015-12-23 | 2017-09-01 | 吉斯藥品公司 | 激酶抑制劑 |
SG10201913878YA (en) | 2016-03-17 | 2020-03-30 | Hoffmann La Roche | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
CN107619388A (zh) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
CN114732910A (zh) | 2017-10-05 | 2022-07-12 | 弗尔康医疗公司 | P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
CN1511830A (zh) * | 1999-03-12 | 2004-07-14 | ���ָ��.Ӣ��ķҩ�﹫˾ | 作为消炎剂的化合物 |
ES2299689T3 (es) | 2002-02-25 | 2008-06-01 | Boehringer Ingelheim Pharmaceuticals Inc. | Compuestos de cicloalquil-uera fusionada con benzo 1,4-disustituido, utiles para el tratamiento de enfermedades por citoquinas. |
GB0320244D0 (en) | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
WO2004101529A1 (ja) | 2003-05-19 | 2004-11-25 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環化合物およびその医薬用途 |
-
2005
- 2005-06-15 US US11/569,809 patent/US7767674B2/en not_active Expired - Fee Related
- 2005-06-15 PL PL05766569T patent/PL1761520T3/pl unknown
- 2005-06-15 SI SI200530351T patent/SI1761520T1/sl unknown
- 2005-06-15 ES ES05766569T patent/ES2308523T3/es active Active
- 2005-06-15 EP EP05766569A patent/EP1761520B1/en active Active
- 2005-06-15 DK DK05766569T patent/DK1761520T3/da active
- 2005-06-15 WO PCT/US2005/021148 patent/WO2006009741A1/en not_active Application Discontinuation
- 2005-06-15 AT AT05766569T patent/ATE400567T1/de not_active IP Right Cessation
- 2005-06-15 PT PT05766569T patent/PT1761520E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
ATE400567T1 (de) | 2008-07-15 |
DK1761520T3 (da) | 2008-10-27 |
PT1761520E (pt) | 2008-09-15 |
EP1761520B1 (en) | 2008-07-09 |
US7767674B2 (en) | 2010-08-03 |
US20080306068A1 (en) | 2008-12-11 |
EP1761520A1 (en) | 2007-03-14 |
PL1761520T3 (pl) | 2008-12-31 |
WO2006009741A1 (en) | 2006-01-26 |
ES2308523T3 (es) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1761520T1 (sl) | Inhibitorji kinaze | |
MY143516A (en) | Kinase inhibitors | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
IL163777A0 (en) | Kinase inhibitors | |
HK1154002A1 (en) | Imidazopyridazinecarbonitriles useful as kinase inhibitors | |
MX2009007077A (es) | Analogos de ciclopamina. | |
TW200624426A (en) | BACE inhibitors | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
MX2007008137A (es) | Triazoloftalazinas como inhibidores de pde2. | |
ZA200701137B (en) | Triazolophthalazines | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
TN2011000293A1 (en) | Protein kinase inhibitors | |
TNSN08191A1 (en) | Kinase inhibitors | |
SG154433A1 (en) | Phthalazine derivatives as parp inhibitors | |
UA85593C2 (uk) | Похідні хіназолінону як інгібітори parp | |
JO2822B1 (en) | Inhibitors of the enzyme kinase P70 S6 and AKT | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
MX2010010406A (es) | Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina. | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
EA201200891A1 (ru) | Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина | |
ATE548364T1 (de) | Aminopyrazolkinasehemmer | |
EP1891082A4 (en) | NEW INHIBITORS OF PYRUVATE KINASE AS THERAPEUTIC AGENTS AGAINST CANCER | |
DOP2005000117A (es) | Inhibidores de quinasa | |
UA97130C2 (en) | Cyclopamine derivatives |